Adverse event occurrence following use of tetanus, diphtheria and acellular pertussis adsorbed vaccine – Tdap –, São Paulo, SP, Brazil, 2015-2016


Publication type
Article
Language
English
Access rights
Open Access
Appears in Collections:
Metrics
Abstract
Objective to describe occurrence of adverse events following immunization (AEFI) with Tdap vaccine during pregnancy. Methods this was a descriptive study using data from reports by participants in an effectiveness and immunogenicity study conducted in two hospitals in São Paulo, SP, Brazil, from 2015 to 2016. Results of the 201 mothers included in the study, 48 (23.9%) had at least one AEFI; 60 symptoms related to Tdap use were identified – pain (22.4%), swelling (2.5%), fever (1.5%), somnolence (1.0%), redness (0.5%), vomiting (0.5%), headache (0.5%), local reaction (0.5%), and fatigue (0.5%); no rare, very rare, or extremely rare adverse events were reported; all events were considered to be expected, as they are described in the vaccine package insert; outcome of all events was recovery without sequelae. Conclusion Tdap vaccine in the form adopted by the National Immunization Program is safe; no unexpected adverse events were identified among vaccinated pregnant women.
Reference
Gattas VL, Luna EJA, Sato APS, Fernandes EG, Vaz-de-Lima LR.A., Sato HK, et al. Adverse event occurrence following use of tetanus, diphtheria and acellular pertussis adsorbed vaccine – Tdap –, São Paulo, SP, Brazil, 2015-2016. Epidemiol. Serv. Saude. 2020 May;29(2):e2019280. doi:10.5123/s1679-49742020000200027.
Link to cite this reference
https://repositorio.butantan.gov.br/handle/butantan/3686
Issue Date
2020


Files in This Item:

Existing users please Login
10.5123s1679-49742020000200027..pdf
Description:
Size: 239.51 kB
Format: Adobe PDF
Embargoed until January 1, 2999    Request a copy
Show full item record

The access to the publications deposited in this repository respects the licenses from journals and publishers.